# PROXEN NP 660

NDC: 69729-123
Generic name: Naproxen Sodium
Labeler / Manufacturer: OPMX LLC
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20231107

FDA application: ANDA091353

## Active ingredients

- NAPROXEN SODIUM: 220 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69729-123"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69729-123
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=09990b2f-202e-b4df-e063-6394a90a055b